首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1624375

全球蛋白質測定市場規模（按最終用戶、應用、技術、產品類型、地區、範圍和預測）

Global Protein Assays Market Size By End User, By Application, By Technology, By Product, By Type, By Geographic Scope And Forecast

出版日期: 2024年09月29日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

蛋白質測定市場評估，2024 年至 2031 年

蛋白質體學和基因組學研究活動的增加以及對藥物發現和市場開發的重視是蛋白質檢測市場的主要驅動力。據 Verified Market Research 分析師稱，蛋白質檢測市場規模預計在 2023 年超過 25 億美元，到 2031 年將達到 52.5 億美元。

全球對各種疾病新藥的需求推動了藥物研發工作，並且需要使用蛋白質測定法進行蛋白質測量、活性分析和驗證，從而促進市場成長。由於對新藥的需求激增，預計 2024 年至 2031 年期間市場複合年增長率為 9.7%。

蛋白質測定市場定義/概述

蛋白質測定是用於量化和分析生物材料中蛋白質的濃度、結構和功能的技術。這些測試在許多科學領域都很重要，包括生物化學、分子生物學和醫學研究。蛋白質測定具有廣泛的應用，包括藥物開發、臨床診斷、生物標記識別和蛋白質純化。

此外，在藥物研發中，蛋白質測定用於透過評估候選藥物與目標蛋白質的相互作用來評估其功效。在臨床診斷中，蛋白質測定對於檢測有助於診斷疾病或評估治療效果的特定生物標記非常重要。

研發活動的增加將如何影響市場？

生物技術和製藥業的研發活動顯著成長，特別是在藥物發現、開發和製造程序方面。這些研發活動中使用蛋白質測定來進行蛋白質定量、藥物測試以及確定藥物的功效和安全性。研發支出的增加，加上對創新療法和個人化醫療的需求的增加，是蛋白質檢測市場的主要驅動力。

更為精細、靈敏和快速的蛋白質測定方法的開發將提高蛋白質分析的效率。比色法、螢光法和發光法已經發展，可以提供更準確、更可靠的蛋白質含量測量。自動化和小型化是技術突破的兩個例子，它們可以實現高通量篩選，同時減少蛋白質分析的時間和成本。這些技術進步正在增強蛋白質檢測在各種應用中的吸引力和適用性，有助於擴大市場。

基因組學、蛋白質組學和個人化醫療等生命科學領域的全球成長正在增加對蛋白質測定的需求。瞭解和分析蛋白質對於這些領域的許多應用至關重要，包括生物標記的發現、疾病研究和治療開發。

此外，慢性病發病率的增加以及對新診斷和治療方法的需求正在推動臨床研究和診斷對蛋白質檢測的需求，從而擴大市場。

阻礙蛋白質測定市場成長的主要障礙是什麼？

由於不同測試平台和方法缺乏標準化，蛋白質檢測市場的發展受到阻礙，導致結果的可重複性和可比性問題。這種差異在需要精確測量的研究和臨床環境中尤其明顯，導致採用緩慢。

蛋白質檢測的開發和商業化，特別是用於診斷和治療應用的檢測，受到美國食品藥物管理局 (FDA) 和歐洲藥品管理局 (EMA) 等機構制定的嚴格監管標準的約束。以這種方式與監管機構打交道既費時又費錢，尤其給新進者、中小型企業帶來沉重的負擔。此外，不斷遵守不斷變化的規範和標準會在資源和技能方面造成障礙，從而限制市場擴張。

Increased research activity in proteomics and genomics, as well as a greater emphasis on medication discovery and development, are significant drivers fueling the Protein Assays Market. According to the analyst from Verified Market Research, the Protein Assays Market is estimated to reach a valuation of USD 5.25 Billion by 2031, surpassing a revenue of aroundUSD 2.5 Billion valued in 2023.

The global desire for new medications for a wide range of diseases is driving drug research and development efforts, demanding the usage of protein assays for protein measurement, activity analysis, and validation, consequently increasing market growth. This surge in demand for new drugs enables the market to grow at aCAGR of 9.7% from 2024 to 2031.

Protein Assays Market: Definition/ Overview

Protein assays are techniques for quantifying and analyzing the concentration, structure, and function of proteins in a biological material. These tests are critical in many scientific areas, including biochemistry, molecular biology, and medical research. Protein assays have a wide range of applications, including drug development, clinical diagnostics, biomarker identification, and protein purification.

Furthermore, in drug discovery, protein assays are used to evaluate the efficacy of putative drug candidates by evaluating their interactions with target proteins. Protein assays are important in clinical diagnostics because they detect specific biomarkers that help diagnose diseases and evaluate therapy responses.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

How do the Increasing Research and Development Activities Influence the Market?

There is tremendous growth in research and development (R&D) activity in the biotechnology and pharmaceutical industries, particularly in medication discovery, development, and manufacturing procedures. Protein assays are used in these R&D operations to quantify proteins, test drugs, and determine the efficacy and safety of pharmaceutical goods. Increased R&D expenditure, combined with increased demand for innovative therapies and personalized medicine, is a primary driver of the Protein Assays Market.

The development of more sophisticated, sensitive, and faster protein assay methods improves the efficiency of protein analysis. Colorimetric, fluorometric, and luminescence assays have evolved to provide more accurate and reliable measures of protein content. Automation and miniaturization are two examples of technological breakthroughs that enable high-throughput screening while reducing the time and expense involved with protein analysis. These technical advancements increase the appeal and applicability of protein assays in a variety of applications, hence boosting market expansion.

The global growth of the life sciences sector, which includes genomics, proteomics, and personalized medicine, has increased demand for protein assays. Understanding and analyzing proteins is critical for many applications in these domains, including biomarker discovery, disease research, and treatment development.

Furthermore, the growing frequency of chronic diseases, as well as the need for new diagnoses and therapies, drive demand for protein assays in clinical research and diagnostics, resulting in market expansion.

Which are the Primary Obstacles Hindering the Growth of Protein Assays Market?

The absence of standardization across different test platforms and methods poses a significant difficulty in the Protein Assays Market, resulting in problems with reproducibility and comparability of results. This discrepancy is especially significant in research and clinical contexts, where precise measurements are required, and causing delayed adoption.

Protein assay development and commercialization, particularly for diagnostic or therapeutic uses, are subject to severe regulatory standards imposed by agencies such as the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Navigating these regulatory routes is time-consuming and expensive, particularly for newer and smaller businesses. Also, ongoing compliance with changing norms and standards presents a barrier in terms of both resources and skill, limiting market expansion.

Category-Wise Acumens

How do Ease of Use and Convenience Contribute to the Sales of Dye-binding Assays?

According to VMR analysis, the dye-binding assays segment is estimated to hold the largest market share in the type segment during the forecast period. Dye-binding assays provide a simple and rapid method for protein quantification that may be carried out in most laboratory settings without the use of costly equipment or highly specialized skills. They are a popular choice among researchers and technicians due to their simplicity and accessibility, especially for routine analysis and applications requiring high throughput.

Economic factors play an important influence in the use of certain tests in research and industrial applications. Dye-binding assays are often less expensive than other types of protein assays, making them an appealing alternative for labs with tight budgets or those who need to run a large number of assays regularly. The decreased cost per test enables broader application in a variety of settings, ranging from academic research to industrial quality control.

Furthermore, dye-binding assays and other leading segments are often compatible with a wide variety of samples, such as cell lysates, serum, and recombinant proteins. This versatility allows them to be used in a wide range of research domains and applications, from fundamental biological research to medication discovery and development. Furthermore, their capacity to adapt and integrate with current protocols and equipment adds to their widespread adoption and commercial dominance.

What factors drive the protein assays for Drug Discovery and Development?

The drug discovery and development segment is estimated to grow at the highest CAGR in the Protein Assays Market during the forecast period. The pharmaceutical and biotechnology businesses are increasing their investment in R&D activities. This is in reaction to the rising demand for new therapeutic medications to meet unmet medical requirements such as chronic diseases, cancer, and rare disorders. Protein assays play an important part in the drug development process, from initial screening to target selection and validation, making them must-have tools in R&D laboratories.

Furthermore, there is a growing emphasis on personalized medicine, which seeks to customize treatments to specific patient profiles such as genetic makeup and protein expression patterns. Protein assays are critical for discovering and quantifying biomarkers that might predict medication response or toxicity, hence facilitating the creation of more tailored and effective treatments. This personalized approach to drug development is primarily reliant on powerful protein analysis techniques, emphasizing the significance of the Protein Assays Market in drug discovery and development.

Country/Region-wise Acumens

How does a Strong Biotechnology Sector Influence the Market Dynamics of North America?

According to VMR analysts, North America is estimated to dominate the Protein Assays Market during the forecast period. North America is home to some of the world's largest and most important biotechnology and pharmaceutical businesses, which make significant investments in research and development (R&D). This strong R&D environment is bolstered by significant investment in innovation, resulting in high demand for protein assays in drug discovery, development procedures, and disease research. The existence of these industrial titans, together with a thriving ecosystem of smaller biotech firms and start-ups, fuels the demand for protein assays to support their substantial research operations.

Furthermore, the region has a sophisticated research infrastructure, including world-class universities, research institutions, and clinical research organizations (CROs). These organizations frequently interact with the biotech and pharmaceutical industries on research projects, increasing demand for protein assays.

Will High Healthcare Expenditure in China and India Prove Fruitful for the Asia Pacific Market?

Asia Pacific region is estimated to be the most opportunistic region for the Protein Assays Market during the forecast period. Countries in the Asia Pacific, such as China, India, South Korea, and Singapore, are experiencing significant economic growth, which has resulted in increasing healthcare spending and investment in life sciences research. Governments and private sector players are making major investments in healthcare infrastructure, research centers, and biotechnology parks, creating a favorable environment for the Protein Assays Market to grow. This funding aims to improve healthcare outcomes and promote innovation in drug research and diagnostics, where protein assays play an important role.

Furthermore, academic and clinical research are becoming increasingly important in the Asia Pacific area, with countries aspiring to become hubs of innovation and scientific discovery. This includes major investments in higher education and research institutions, as well as efforts to develop relationships among academics, government, and industry. The emphasis on research areas such as cancer, infectious diseases, and genetics, where protein analysis is critical, is resulting in an expanded use of protein assays.

Competitive Landscape

The competitive landscape of the Protein Assays Market is defined by a dynamic and innovative environment in which entities compete for prominence through technological breakthroughs, product portfolio expansion, and penetration into emerging markets.

Some of the prominent players operating in the Protein Assays Market include:

Thermo Fisher Scientific, Bio-Rad Laboratories, Merck KGaA, Danaher Corporation, Cell Signaling Technology, Abcam plc, PerkinElmer Inc., QIAGEN, Lonza, Bio-Techne, BioVision Inc, Geno Technology Inc.

Latest Developments

In October 2023, Thermo Fisher Scientific introduced their new "QuantiFluor ONE Protein Assay". This assay is intended to provide high sensitivity and a large dynamic range for protein measurement in a variety of biological samples.

In September 2023, Merck KGaA collaborated with "AIVITA Animal Health" to develop and commercialize a novel blood test for the early diagnosis of canine parvovirus. This test utilizes protein assay technology for a faster and more accurate diagnosis.

In August 2023, Bio-Rad Laboratories announced its new "Chemiluminescent Western Blot Detection Kits". These kits provide enhanced sensitivity and lower background noise for Western blot analysis, a crucial protein test technique.

1 INTRODUCTION OF GLOBAL PROTEIN ASSAYS MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL PROTEIN ASSAYS MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL PROTEIN ASSAYS MARKET, BY TYPE

5.1 Overview
5.2 Dye-binding Assays
5.3 Copper-ion-based Assays
5.4 Test Strip-based Assays
5.5 Others

6 GLOBAL PROTEIN ASSAYS MARKET, BY PRODUCT

6.1 Overview
6.2 Reagents
6.3 Kits
6.4 Instruments & Accessories

7 GLOBAL PROTEIN ASSAYS MARKET, BY TECHNOLOGY

7.1 Overview
7.2 Colorimetric-based Protein Assays
7.3 Fluorescence-based Protein Assays
7.4 Absorbance-based Protein Assays

8 GLOBAL PROTEIN ASSAYS MARKET, BY APPLICATION

8.1 Overview
8.2 Drug Discovery and Development
8.3 Disease Diagnosis
8.4 Others

9 GLOBAL PROTEIN ASSAYS MARKET, BY END-USER

9.1 Overview
9.2 Pharmaceutical & Biotechnology Companies
9.3 Hospitals
9.4 Clinical Laboratories
9.5 Academic Institutes
9.6 Others

10 GLOBAL PROTEIN ASSAYS MARKET, BY GEOGRAPHY

10.1 Overview
10.2 North America
- 10.2.1 U.S.
- 10.2.2 Canada
- 10.2.3 Mexico
10.3 Europe
- 10.3.1 Germany
- 10.3.2 U.K.
- 10.3.3 France
- 10.3.4 Rest of Europe
10.4 Asia Pacific
- 10.4.1 China
- 10.4.2 Japan
- 10.4.3 India
- 10.4.4 Rest of Asia Pacific
10.5 Rest of the World
- 10.5.1 Latin America
- 10.5.2 Middle East & Africa

11 GLOBAL PROTEIN ASSAYS MARKET COMPETITIVE LANDSCAPE

11.1 Overview
11.2 Company Market Share
11.3 Vendor Landscape
11.4 Key Development Strategies

12 COMPANY PROFILES

12.1 Bio-Rad Laboratories
- 12.1.1 Overview
- 12.1.2 Financial Performance
- 12.1.3 Product Outlook
- 12.1.4 Key Developments
12.2 Thermo Fisher Scientific
- 12.2.1 Overview
- 12.2.2 Financial Performance
- 12.2.3 Product Outlook
- 12.2.4 Key Developments
12.3 Merck KGaA
- 12.3.1 Overview
- 12.3.2 Financial Performance
- 12.3.3 Product Outlook
- 12.3.4 Key Developments
12.4 Danaher Corporation
- 12.4.1 Overview
- 12.4.2 Financial Performance
- 12.4.3 Product Outlook
- 12.4.4 Key Developments
12.5 Cell Signaling Technology
- 12.5.1 Overview
- 12.5.2 Financial Performance
- 12.5.3 Product Outlook
- 12.5.4 Key Developments
12.6 Abcam plc
- 12.6.1 Overview
- 12.6.2 Financial Performance
- 12.6.3 Product Outlook
- 12.6.4 Key Developments
12.7 PerkinElmer Inc.
- 12.7.1 Overview
- 12.7.2 Financial Performance
- 12.7.3 Product Outlook
- 12.7.4 Key Developments
12.8 QIAGEN
- 12.8.1 Overview
- 12.8.2 Financial Performance
- 12.8.3 Product Outlook
- 12.8.4 Key Developments
12.9 Lonza
- 12.9.1 Overview
- 12.9.2 Financial Performance
- 12.9.3 Product Outlook
- 12.9.4 Key Developments
12.10 Bio-Techne
- 12.10.1 Overview
- 12.10.2 Financial Performance
- 12.10.3 Product Outlook
- 12.10.4 Key Developments